Published in Aust Health Rev on April 20, 2017
The peroxisome proliferator-activated receptor-gamma agonist rosiglitazone decreases bone formation and bone mineral density in healthy postmenopausal women: a randomized, controlled trial. J Clin Endocrinol Metab (2007) 4.01
Acute myocardial infarction. Lancet (2008) 3.59
Bare metal stent restenosis is not a benign clinical entity. Am Heart J (2006) 3.39
Intravenous platelet blockade with cangrelor during PCI. N Engl J Med (2009) 3.31
Changing illness perceptions after myocardial infarction: an early intervention randomized controlled trial. Psychosom Med (2002) 2.97
Extent of, and factors associated with, delay to hospital presentation in patients with acute coronary disease (the GRACE registry). Am J Cardiol (2002) 2.82
Association of statin therapy with outcomes of acute coronary syndromes: the GRACE study. Ann Intern Med (2004) 2.80
Platelet inhibition with cangrelor in patients undergoing PCI. N Engl J Med (2009) 2.52
Randomised trials in general practice--a New Zealand experience in recruitment. N Z Med J (2003) 2.23
Invasive management and late clinical outcomes in contemporary Australian management of acute coronary syndromes: observations from the ACACIA registry. Med J Aust (2008) 2.12
Simple or complex stenting for bifurcation coronary lesions: a patient-level pooled-analysis of the Nordic Bifurcation Study and the British Bifurcation Coronary Study. Circ Cardiovasc Interv (2011) 2.08
Renal failure after percutaneous coronary intervention is associated with high mortality. Catheter Cardiovasc Interv (2005) 2.00
Maori have worse outcomes after coronary artery bypass grafting than Europeans in New Zealand. N Z Med J (2013) 1.96
Management and 6-month outcomes in elderly and very elderly patients with high-risk non-ST-elevation acute coronary syndromes: The Global Registry of Acute Coronary Events. Eur Heart J (2008) 1.86
Safety and efficacy of a multi-electrode renal sympathetic denervation system in resistant hypertension: the EnligHTN I trial. Eur Heart J (2013) 1.77
Acute coronary syndrome care across Australia and New Zealand: the SNAPSHOT ACS study. Med J Aust (2013) 1.69
Inequitable provision of optimal services for patients with chronic heart failure: a national geo-mapping study. Med J Aust (2007) 1.67
Unprotected left main revascularization in patients with acute coronary syndromes. Eur Heart J (2009) 1.66
Decreased bone density in men on methadone maintenance therapy. Addiction (2010) 1.63
Telehealth interventions for the secondary prevention of coronary heart disease: a systematic review. Eur J Cardiovasc Prev Rehabil (2009) 1.63
Five years of anti-resorptive activity after a single dose of zoledronate--results from a randomized double-blind placebo-controlled trial. Bone (2012) 1.62
The management of acute coronary syndrome patients across New Zealand in 2012: results of a third comprehensive nationwide audit and observations of current interventional care. N Z Med J (2013) 1.60
Predictors and impact of major hemorrhage on mortality following percutaneous coronary intervention from the REPLACE-2 Trial. Am J Cardiol (2007) 1.59
Agreement between stereoscopic photographs, clinical assessment, Heidelberg retina tomograph and digital stereoscopic optic disc camera in estimating vertical cup:disc ratio. Clin Experiment Ophthalmol (2005) 1.58
Three-dimensional and two-dimensional quantitative coronary angiography, and their prediction of reduced fractional flow reserve. Eur Heart J (2010) 1.58
Further development of an illness perception intervention for myocardial infarction patients: a randomized controlled trial. J Psychosom Res (2009) 1.58
Early and sustained survival benefit associated with statin therapy at the time of percutaneous coronary intervention. Circulation (2002) 1.58
Balloon aortic valvuloplasty to bridge and triage patients in the era of trans-catheter aortic valve implantation. Catheter Cardiovasc Interv (2012) 1.57
Implications of diabetes in patients with acute coronary syndromes. The Global Registry of Acute Coronary Events. Arch Intern Med (2004) 1.57
Impact of red blood cell transfusion on platelet activation and aggregation in healthy volunteers: results of the TRANSFUSION study. Eur Heart J (2010) 1.55
Relation of inflammation and benefit of statins after percutaneous coronary interventions. Circulation (2003) 1.55
New P2Y12 inhibitors versus clopidogrel in percutaneous coronary intervention: a meta-analysis. J Am Coll Cardiol (2010) 1.54
Intracoronary shear-related up-regulation of platelet P-selectin and platelet-monocyte aggregation despite the use of aspirin and clopidogrel. Blood (2010) 1.52
Acute coronary syndromes: consensus recommendations for translating knowledge into action. Med J Aust (2010) 1.52
Relationship of ST elevation in lead aVR with angiographic findings and outcome in non-ST elevation acute coronary syndromes. Am Heart J (2007) 1.51
Preoperative estimates of glomerular filtration rate as predictors of outcome after surgery: a systematic review and meta-analysis. Anesthesiology (2013) 1.51
Impact of medical consultation frequency on modifiable risk factors and medications at 12 months after acute coronary syndrome in the CHOICE randomised controlled trial. Int J Cardiol (2010) 1.50
The skeletal effects of the tyrosine kinase inhibitor nilotinib. Bone (2011) 1.50
Feasibility of simultaneous bilateral carotid artery stenting. Catheter Cardiovasc Interv (2004) 1.50
Effect of providing information about normal test results on patients' reassurance: randomised controlled trial. BMJ (2007) 1.49
2015 ESC Guidelines for the Management of Acute Coronary Syndromes in Patients Presenting Without Persistent ST-segment Elevation. Rev Esp Cardiol (Engl Ed) (2015) 1.49
Differences in treatment and management of indigenous and non-indigenous patients presenting with chest pain: results of the Heart Protection Partnership (HPP) study. Heart Lung Circ (2008) 1.48
Acute primary angle closure attack does not cause an increased cup-to-disc ratio. Ophthalmology (2010) 1.45
In-hospital outcomes associated with fibrinolytic and thienopyridine use in patients with ST-segment elevation acute myocardial infarction. The global registry of acute coronary events. Rev Esp Cardiol (2009) 1.42
Cardiovascular health in New Zealand: areas of concern and targets for improvement in 2008 and beyond. N Z Med J (2008) 1.41
Utility of routine functional testing after percutaneous transluminal coronary angioplasty: results from the ROSETTA registry. J Invasive Cardiol (2004) 1.40
Use of automated home blood pressure monitoring in pregnancy: is it safe? Am J Obstet Gynecol (2002) 1.40
Bone metabolism during long-term treatment with imatinib. Leuk Lymphoma (2013) 1.40
Inflammation and coronary artery disease. Am Heart J (2005) 1.39
Lifestyle risk reduction interventions in atrial fibrillation: a systematic review. Eur J Prev Cardiol (2012) 1.39
Intracoronary ECG ST-segment recovery during primary percutaneous intervention for ST-segment myocardial infarction: insights from a cardiac MRI study. Catheter Cardiovasc Interv (2012) 1.39
Six-month outcomes in a multinational registry of patients hospitalized with an acute coronary syndrome (the Global Registry of Acute Coronary Events [GRACE]). Am J Cardiol (2004) 1.39
Relation of platelet inactivation with intravenous glycoprotein IIb/IIIa antagonists to major bleeding (from the GOLD study). Am J Cardiol (2002) 1.37
Prolonged antiresorptive activity of zoledronate: a randomized, controlled trial. J Bone Miner Res (2010) 1.37
Prognostic impact of types of atrial fibrillation in acute coronary syndromes. Am J Cardiol (2009) 1.31
Vitamin D repletion in patients with primary hyperparathyroidism and coexistent vitamin D insufficiency. J Clin Endocrinol Metab (2005) 1.30
Global patterns of use of antithrombotic and antiplatelet therapies in patients with acute coronary syndromes: insights from the Global Registry of Acute Coronary Events (GRACE). Am Heart J (2003) 1.29
Acute Coronary Syndrome patients in New Zealand receive less invasive management when admitted to hospitals without invasive facilities. N Z Med J (2004) 1.29
Management of patients admitted with an Acute Coronary Syndrome in New Zealand: results of a comprehensive nationwide audit. N Z Med J (2004) 1.24
What do people with glaucoma know about their condition? A comparative cross-sectional incidence and prevalence survey. Clin Experiment Ophthalmol (2008) 1.23
Feasibility and cost-effectiveness of stroke prevention through community screening for atrial fibrillation using iPhone ECG in pharmacies. The SEARCH-AF study. Thromb Haemost (2014) 1.21
A common variant at chromosome 9P21.3 is associated with age of onset of coronary disease but not subsequent mortality. Circ Cardiovasc Genet (2010) 1.21
Access to catheterisation facilities in patients admitted with acute coronary syndrome: multinational registry study. BMJ (2005) 1.20
Prehospital Delay in Patients With Acute Coronary Syndromes (from the Global Registry of Acute Coronary Events [GRACE]). Am J Cardiol (2009) 1.18
Association of genetic variation in the natriuretic peptide system with cardiovascular outcomes. J Mol Cell Cardiol (2011) 1.17
Participating in cardiac rehabilitation: a systematic review and meta-synthesis of qualitative data. Eur J Prev Cardiol (2012) 1.16
Patients admitted with an acute coronary syndrome (ACS) in New Zealand in 2007: results of a second comprehensive nationwide audit and a comparison with the first audit from 2002. N Z Med J (2010) 1.15
Effect of clopidogrel pretreatment on inflammatory marker expression in patients undergoing percutaneous coronary intervention. Am J Cardiol (2004) 1.15
The antiresorptive effects of a single dose of zoledronate persist for two years: a randomized, placebo-controlled trial in osteopenic postmenopausal women. J Clin Endocrinol Metab (2008) 1.14
Screening to identify unknown atrial fibrillation. A systematic review. Thromb Haemost (2013) 1.14
Comparative effectiveness of population interventions to improve access to reperfusion for ST-segment-elevation myocardial infarction in Australia. Circ Cardiovasc Qual Outcomes (2012) 1.14
Heart failure self-care in developed and developing countries. J Card Fail (2009) 1.11
Management of non ST-elevationacute coronary syndrome patients in New Zealand: a longitudinal analysis. Results from the New Zealand Acute Coronary Syndrome national audits of 2002, 2007 and 2012. N Z Med J (2016) 1.08
Hospital quality improvement initiative for patients with acute coronary syndromes in China: a cluster randomized, controlled trial. Circ Cardiovasc Qual Outcomes (2014) 1.06
Illness perceptions in patients with gout and the relationship with progression of musculoskeletal disability. Arthritis Care Res (Hoboken) (2011) 1.06
Comparison of bivalirudin versus heparin during percutaneous coronary intervention (the Randomized Evaluation of PCI Linking Angiomax to Reduced Clinical Events [REPLACE]-1 trial). Am J Cardiol (2004) 1.06
A randomised study of three different informational AIDS prior to coronary angiography, measuring patient recall, satisfaction and anxiety. Heart Lung Circ (2007) 1.05
Post-Percutaneous Coronary Intervention Angina: A New Performance Measure? JACC Cardiovasc Interv (2015) 1.05
Can an illness perception intervention reduce illness anxiety in spouses of myocardial infarction patients? A randomized controlled trial. J Psychosom Res (2009) 1.05
A multinational investigation of time and traveling costs in attending anticoagulation clinics. Value Health (2008) 1.05
In unstable angina or non-ST-segment acute coronary syndrome, should patients with multivessel coronary artery disease undergo multivessel or culprit-only stenting? J Am Coll Cardiol (2007) 1.04
Reduced immediate ischemic events with cangrelor in PCI: a pooled analysis of the CHAMPION trials using the universal definition of myocardial infarction. Am Heart J (2012) 1.04